NASDAQ:AEMD • US00808Y6041
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for AETHLON MEDICAL INC (AEMD).
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2025-08-14 | HC Wainwright & Co. | Reiterate | Neutral -> Neutral |
| 2025-03-10 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-02-19 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-01-30 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-11-15 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-06-24 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2024-03-04 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2023-10-24 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2022-11-15 | Maxim Group | Downgrade | Buy -> Hold |
| 2021-06-25 | HC Wainwright & Co. | Maintains | Buy |
| 2021-06-01 | HC Wainwright & Co. | Initiate | Buy |
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 660K 1.54% | 290K -56.06% | 570K 96.55% | -100.00% | 9.051M | 24.515M 170.85% | 35.747M 45.82% | 48.405M 35.41% | ||||||
| EBITDA YoY % growth | -7.85M -33.05% | -10.3M -31.21% | -11.66M -13.20% | N/A -5.30% | N/A 26.69% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -7.89M -33.05% | -10.42M -32.07% | -11.9M -14.20% | -13.661M -6.19% | -9.489M 26.09% | -7.713M 17.42% | -9.621M -24.75% | -13.306M -38.30% | -16.173M -21.55% | -12.419M 23.22% | -3.141M 74.71% | 2.989M 195.17% | 9.902M 231.28% | |
| Operating Margin | -1,195.45% | -3,593.10% | -2,087.72% | N/A | N/A | N/A | N/A | N/A | N/A | -137.21% | -12.81% | 8.36% | 20.46% | |
| EPS YoY % growth | N/A 77.50% | -568.00 0.08% | -472.00 16.90% | -443.36 16.95% | -58.96 65.99% | -9.85 92.61% | -2.25 77.11% | -0.51 77.38% | -0.62 -22.00% | -0.31 50.82% | -0.08 73.33% | 0.07 187.50% | 0.24 242.86% |
All data in USD
| Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | |
|---|---|---|---|---|---|
| EPS Q2Q % growth | -2.06 97.42% | -0.77 90.94% | -0.73 80.50% | -0.49 80.02% | -0.46 77.42% |
| Revenue Q2Q % growth | |||||
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -2.241M -11.81% | -3.269M -82.39% | -3.328M -125.42% | -3.506M -72.82% | -3.482M -55.39% |
All data in USD
7 analysts have analysed AEMD and the average price target is 11.73 USD. This implies a price increase of 440.55% is expected in the next year compared to the current price of 2.17.
AETHLON MEDICAL INC (AEMD) will report earnings on 2026-06-24, after the market close.
The consensus EPS estimate for the next earnings of AETHLON MEDICAL INC (AEMD) is -2.06 USD and the consensus revenue estimate is 0 USD.
The consensus rating for AETHLON MEDICAL INC (AEMD) is 45.7143 / 100 . This indicates that analysts generally have a neutral outlook on the stock.